Spire Healthcare Share News (SPI)

Wednesday broker round-up

(ShareCast News) - Ibstock: Jefferies reiterates buy with a target price of 190p. Legal & General: Barclays maintains equal-weight with a 194p target. Glencore: UBS reiterates buy with a 220p target. Booker: HSBC stays at neutral with a 200p target. Spire Healthcare: Berenberg reiterates buy with

UK Dividends Calendar - Next 7 Days

Wednesday broker round-up

(ShareCast News) - Hochschild Mining: UBS downgrades to neutral with a target price of 160p. Esure Group: JP Morgan keeps at overweight with a 330p target. Royal Dutch Shell: RBC reiterates outperform with a target price of 2000p and JP Morgan stays atneutral with a target price of 1630p. National

EXTRA: Mediclinic Says Trading In Line, Focus On Al Noor Integration

TOP NEWS: Mediclinic Says Traded In Line, Focus On Al Noor Integration

Spire Healthcare Says 2016 On Track To Meet Previous Guidance

Spire Healthcare deputy chairman to step down

(ShareCast News) - Spire Healthcare's deputy chairman and senior independent director John Gildersleeve will stand down from the board for personal reasons. The FTSE 250 private hospitals operator said Gildersleeve will stay on as a director until a new independent non-executive director has been ap

Spire Healthcare Deputy Chairman Gildersleeve To Step Down

BROKER RATINGS SUMMARY: Jefferies And Shore Say Hold AstraZeneca

BROKER RATINGS SUMMARY: Credit Suisse Prefers Hammerson Over Intu

Mediclinic Sees Strong Patient Growth At Stable Margins

BROKER RATINGS SUMMARY: Jefferies Adjusts Ratings On Retailers

LONDON BRIEFING: Premier Foods Receives Higher US Takeover Offer

BROKER RATINGS SUMMARY: JPMorgan Starts Countryside At Overweight

BROKER RATINGS SUMMARY: HSBC Downgrades Barclays To Hold From Buy